Q1FY24 Results - Investor Presentation
Financial Overview (Reported)
| Q1FY24 Performance summary - P&L
P&L (RM' mil)
Q4FY231
Q1FY24
QoQ Change
Q1FY231
Q1FY24
YoY Change
Total Income
1,152
1,202
4%
1,153
1,202
4%
NII
824
809
(2%)
863
809
(6%)
NOII
3281
393
20%
2891
393
36%
MFRS 17 restatement impact
(8)
N/A
(9)
N/A
Expenses
(556)
(508)
(9%)
(544)
(508)
(7%)
PBP
597
694
16%
609
694
14%
Net Impairment
PBT
(51)
(190)
>100%
(64)
(190)
>100%
546
504
(8%)
545
504
(8%)
PAT
420
403
(4%)
425
403
(5%)
-Profit from Continuing Operations²
420¹
352
(16%)
3871
352
(9%)
- Profit from Discontinued Operation³
51
N/A
39
51
33%
PATMI
420
378
(10%)
410
378
(8%)
- PATMI from Continuing Operations²
420¹
352
(16%)
3871
352
(9%)
- PATMI from Discontinued Operation³
26
N/A
24
26
9%
Financial Indicators
Q4FY23
Q1FY24
QoQ Change
Q1FY23
Q1FY24
YoY Change
CTI
48.2%
42.2%
(6.0%)
47.2%
42.2%
(4.9%)
NIM
1.84%
1.76%
(0.08%)
2.12%
1.76%
(0.36%)
ROE (Annualised)
9.6%
8.3%
(1.3%)
9.8%
8.3%
(1.5%)
Basic EPS (sen)4
12.70
11.44
(9.9%)
12.40
11.44
(7.7%)
Net Assets per Share (RM)5
5.45
5.59
2.6%
5.11
5.59
9.3%
1.
Q1FY23 & Q4FY23 P&L numbers are restated following the adoption of MFRS 17 for Insurance Business
2.
3.
4.
Continuing operations comprised Banking operations and Insurance. Insurance mainly consists of Life Insurance (as JV) and General Insurance (as associate from August'22 onwards)
Discontinued operation in Q1FY23 and Q1FY24 comprised General Insurance as subsidiary from April 22 to June 22 and RM51m gain from AmGen divestment completion respectively
Computed based on weighted average number of shares
5.
AmBank Group
Computed based on number of ordinary shares issued at period end (excludes treasury shares)
Q1FY24 Results - Investor Presentation
9View entire presentation